Biote Corp
BTMD
Market cap $160M

5.17 USD

-0.09

1.71%

At close Oct 10, 4:00 PM EDT

1 day

-1.71%

5 days

1.77%

1 month

-10.71%

3 months

-33.72%

6 months

-13.11%

Year to date

9.30%

1 year

-4.26%

5 years

-18.07%

About: Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.

Employees: 194

Healthcare Medicinal Chemicals & Botanical Products

0

Funds holding %

of 6,740 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

350% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 6

220% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 10

74% more capital invested

Capital invested by funds: $69.8M [Q1] → $122M (+$51.9M) [Q2]

50% more funds holding in top 10

Funds holding in top 10: 2 [Q1] → 3 (+1) [Q2]

39% more funds holding

Funds holding: 54 [Q1] → 75 (+21) [Q2]

20.04% more ownership

Funds ownership: 33.7% [Q1] → 53.74% (+20.04%) [Q2]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for BTMD.

See Analyst Rankings

Financial journalist opinion

biote Corp. (BTMD) Q2 2024 Earnings Call Transcript

biote Corp. (NASDAQ:BTMD ) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Szymon Serowiecki – Investor Relations Terry Weber – Chief Executive Officer Bob Peterson – Chief Financial Officer Conference Call Participants Les Sulewski – Truist Securities Jonna Kim – TD Cowen Richard Magnusen – B. Riley Securities George Kelly – ROTH Capital Kaumil Gajrawala – Jefferies Operator Good day, and welcome to the Biote Second Quarter 2024 Earnings Conference Call.

biote Corp. (BTMD) Q2 2024 Earnings Call Transcript

Biote Reports Second Quarter 2024 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights (All financial result comparisons made are against the prior-year period) Revenue of $49.2 million Procedure revenue of $38.4 million Gross profit margin of 68.9%, including a $1.2 millio.

Biote Reports Second Quarter 2024 Financial Results

Zacks Investment Research

Buy These 4 Stocks With Rising Cash Flows for Big Gains

Cash indicates a company's true financial health. It is the key to its existence, development and success.

Buy These 4 Stocks With Rising Cash Flows for Big Gains

Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide second quarter financial results on Thursday, August 8, 2024, after the close of the market. A conference call to discuss the firm's results will be held at 5:00 p.m. ET. the same day. Conference Call Details The conference call may.

Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call

Zacks Investment Research

biote Corp. (BTMD) is on the Move, Here's Why the Trend Could be Sustainable

biote Corp. (BTMD) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

biote Corp. (BTMD) is on the Move, Here's Why the Trend Could be Sustainable

Zacks Investment Research

Buy 4 Stocks With Rising Cash Flows to Enrich Your Portfolio

Achieving profit is, no doubt, a company's goal, but having a healthy cash flow is imperative to its existence, development and success. So, ASC, TXO, GPRK and BTMD are worth buying.

Buy 4 Stocks With Rising Cash Flows to Enrich Your Portfolio

Zacks Investment Research

5 Stocks With Recent Price Strength to Tap Wall Street Rally

Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are ADMA, AMSC, BTMD, LINC, CORT.

5 Stocks With Recent Price Strength to Tap Wall Street Rally

Zacks Investment Research

Wall Street Analysts Think biote Corp. (BTMD) Could Surge 25.44%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 25.4% in biote Corp. (BTMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wall Street Analysts Think biote Corp. (BTMD) Could Surge 25.44%: Read This Before Placing a Bet

Zacks Investment Research

biote Corp. (BTMD) is on the Move, Here's Why the Trend Could be Sustainable

biote Corp. (BTMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

biote Corp. (BTMD) is on the Move, Here's Why the Trend Could be Sustainable

Zacks Investment Research

biote Corp. (BTMD) Surges 10.4%: Is This an Indication of Further Gains?

biote Corp. (BTMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

biote Corp. (BTMD) Surges 10.4%: Is This an Indication of Further Gains?

See News Rankings

Charts implemented using Lightweight Charts™